News

Vivanza Biosciences Limited will hold a board meeting on August 17, 2026, at its registered office to approve the Director`s Report and Secretarial Audit Report for the financial year 2025-26, convene the 44th Annual General Meeting (AGM), appoint Mr. Chintan K. Patel as Scrutinizer for the e-voting and poll process, fix September 04, 2026, as the cut-off date for the AGM, and seek approval for the adoption of the Memorandum of Association and Articles of Association, proposed borrowings under Section 180(1)(c) of the Companies Act, 2013, and proposed transactions under Section 185 of the Companies Act, 2013, as applicable, along with proposed investments, loans, guarantees and/or securities under Section 186 of the Companies Act, 2013.

Net profit of Vivanza Biosciences rose 66.67% to Rs 0.15 crore in the quarter ended June 2026 as against Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 3.91% to Rs 9.29 crore in the quarter ended June 2026 as against Rs 8.94 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales9.298.94 4 OPM %-0.861.68 - PBDT0.190.09 111 PBT0.180.09 100 NP0.150.09 67 Powered by Capital Market - Live News

Vivanza Biosciences has postponed the meeting of the Board of Directors which was scheduled to be held on 1 August 2026. The meeting will now be held on 7 August 2026.

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 1 August 2026.

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 18 June 2026.